MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells - PubMed (original) (raw)
. 2013 Feb 21;32(8):1059-65.
doi: 10.1038/onc.2012.106. Epub 2012 Apr 9.
S Lindner, A Bohrer, J Maurer, K De Preter, S Lefever, L Heukamp, S Schulte, J Molenaar, R Versteeg, T Thor, A Künkele, J Vandesompele, F Speleman, H Schorle, A Eggert, A Schramm
Affiliations
- PMID: 22484425
- DOI: 10.1038/onc.2012.106
MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells
J H Schulte et al. Oncogene. 2013.
Abstract
Neuroblastoma is an embryonal tumor with a heterogeneous clinical course. The tumor is presumed to be derived from the neural crest, but the cells of origin remain to be determined. To date, few recurrent genetic changes contributing to neuroblastoma formation, such as amplification of the MYCN oncogene and activating mutations of the ALK oncogene, have been identified. The possibility to model neuroblastoma in mice allows investigation of the cell of origin hypothesis in further detail. Here we present the evidence that murine neural crest progenitor cells can give rise to neuroblastoma upon transformation with MYCN or ALK(F1174L). For this purpose we used JoMa1, a multipotent neural crest progenitor cell line, which is kept in a viable and undifferentiated state by a tamoxifen-activated c-Myc transgene (c-MycER(T)). Expression of MYCN or ALK(F1174L), one of the oncogenic ALK variants identified in primary neuroblastomas, enabled these cells to grow independently of c-MycER(T) activity in vitro and caused formation of neuroblastoma-like tumors in vivo in contrast to parental JoMa1 cells and JoMa1 cells-expressing TrkA or GFP. Tumorigenicity was enhanced upon serial transplantation of tumor-derived cells, and tumor cells remained susceptible to the MYC-inhibitor, NBT-272, indicating that cell growth depended on functional MYCN. Our findings support neural crest progenitor cells as the precursor cells of neuroblastoma, and indicate that neuroblastomas arise as their malignant progeny.
Similar articles
- Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells.
Schönherr C, Ruuth K, Kamaraj S, Wang CL, Yang HL, Combaret V, Djos A, Martinsson T, Christensen JG, Palmer RH, Hallberg B. Schönherr C, et al. Oncogene. 2012 Dec 13;31(50):5193-200. doi: 10.1038/onc.2012.12. Epub 2012 Jan 30. Oncogene. 2012. PMID: 22286764 - Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells.
Montavon G, Jauquier N, Coulon A, Peuchmaur M, Flahaut M, Bourloud KB, Yan P, Delattre O, Sommer L, Joseph JM, Janoueix-Lerosey I, Gross N, Mühlethaler-Mottet A. Montavon G, et al. Oncotarget. 2014 Jun 30;5(12):4452-66. doi: 10.18632/oncotarget.2036. Oncotarget. 2014. PMID: 24947326 Free PMC article. - Alternative NHEJ pathway proteins as components of MYCN oncogenic activity in human neural crest stem cell differentiation: implications for neuroblastoma initiation.
Newman EA, Chukkapalli S, Bashllari D, Thomas TT, Van Noord RA, Lawlor ER, Hoenerhoff MJ, Opipari AW, Opipari VP. Newman EA, et al. Cell Death Dis. 2017 Dec 13;8(12):3208. doi: 10.1038/s41419-017-0004-9. Cell Death Dis. 2017. PMID: 29238067 Free PMC article. - The MYCN oncogene and differentiation in neuroblastoma.
Westermark UK, Wilhelm M, Frenzel A, Henriksson MA. Westermark UK, et al. Semin Cancer Biol. 2011 Oct;21(4):256-66. doi: 10.1016/j.semcancer.2011.08.001. Epub 2011 Aug 9. Semin Cancer Biol. 2011. PMID: 21849159 Review. - Neuroblastoma models for insights into tumorigenesis and new therapies.
Kiyonari S, Kadomatsu K. Kiyonari S, et al. Expert Opin Drug Discov. 2015 Jan;10(1):53-62. doi: 10.1517/17460441.2015.974544. Epub 2014 Oct 25. Expert Opin Drug Discov. 2015. PMID: 25345447 Review.
Cited by
- Neuroblastoma Origin and Therapeutic Targets for Immunotherapy.
Kholodenko IV, Kalinovsky DV, Doronin II, Deyev SM, Kholodenko RV. Kholodenko IV, et al. J Immunol Res. 2018 Jul 11;2018:7394268. doi: 10.1155/2018/7394268. eCollection 2018. J Immunol Res. 2018. PMID: 30116755 Free PMC article. Review. - Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia.
Vivancos Stalin L, Gualandi M, Schulte JH, Renella R, Shakhova O, Mühlethaler-Mottet A. Vivancos Stalin L, et al. Front Oncol. 2019 Apr 16;9:275. doi: 10.3389/fonc.2019.00275. eCollection 2019. Front Oncol. 2019. PMID: 31058082 Free PMC article. - Glycogen synthase kinase 3 controls migration of the neural crest lineage in mouse and Xenopus.
Gonzalez Malagon SG, Lopez Muñoz AM, Doro D, Bolger TG, Poon E, Tucker ER, Adel Al-Lami H, Krause M, Phiel CJ, Chesler L, Liu KJ. Gonzalez Malagon SG, et al. Nat Commun. 2018 Mar 19;9(1):1126. doi: 10.1038/s41467-018-03512-5. Nat Commun. 2018. PMID: 29555900 Free PMC article. - Involvement of seven in absentia homolog-1 in ethanol-induced apoptosis in neural crest cells.
Sun H, Chen X, Yuan F, Liu J, Zhao Y, Chen SY. Sun H, et al. Neurotoxicol Teratol. 2014 Nov-Dec;46:26-31. doi: 10.1016/j.ntt.2014.08.006. Epub 2014 Sep 3. Neurotoxicol Teratol. 2014. PMID: 25193017 Free PMC article. - Immune response modulation by Galectin-1 in a transgenic model of neuroblastoma.
Büchel G, Schulte JH, Harrison L, Batzke K, Schüller U, Hansen W, Schramm A. Büchel G, et al. Oncoimmunology. 2016 Feb 18;5(5):e1131378. doi: 10.1080/2162402X.2015.1131378. eCollection 2016 May. Oncoimmunology. 2016. PMID: 27467948 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical